APPLY TO THE OPEN CALL INNO4COV-19

INNO4COV-19 Open Call aims to provide financial support to companies with the goal of accelerating the development and commercialization of innovative solutions that tackle COVID-19 and that have already been validated in lab environments (TRL6 or higher).

©disq - stock.adobe.com

Eligibility criteria

Companies or small consortia of companies established in one of the EU Member States or H2020 associated countries.
The sectors of focus may include healthcare / medicine / biotech / biopharma, and IT-related topics (e.g. robotics, automation, electronics, nanotech, etc).

What we offer

Financial support
Up to EUR 100,000 (100% of the total cost of the project)

Tailored support
Guidance from a network of experts at a technical, business and regulatory level for bringing your innovation to the market

Access to specific facilities and infrastructure
Providing added value to your innovations

Media exposure
Highlights through our network

Key dates

We will consider applications in three different rounds.

NOVEMBER 2020 ROUND
Deadline: 30/11/2020 – Funding decision: +40days

MARCH 2021 ROUND
Deadline: 31/03/2021 – Funding decision: +40days

May 2021 ROUND
Deadline: 31/03/2021 – Funding decision: +40days

More News

Tiprelestat will be administered to patients hospitalized due to COVID-19 with the goal of reducing the duration of severe COVID-19.
Tiprelestat will be administered to patients hospitalized due to COVID-19 with the goal of reducing the duration of severe COVID-19. (Photo Credit: Alissa Eckert, MSMI; Dan Higgins, MAMS)

tiakis: Treatment of COVID-19

tiakis Biotech AG announced today that a first patient has been dosed in the COMCOVID trial, a Phase Ib/II trial evaluating the Company’s key investigational ...

Read more …
The paper's main author Vasundara Srinivasan at an X-ray set-up to test protein crystals in the lab. Credit: University of Hamburg, Susanna Gevorgyan (Credit: © University of Hamburg, Susanna Gevorgyan)

Natural substances show promise against coronavirus

Three natural compounds present in foods like green tea, olive oil and red wine are promising candidates for the development of drugs against the coronavirus. ...

Read more …
The molecule has shown great potential to produce a powerful antiviral response against infections with SARS-CoV-2. (Picture: ©NicoElNino/adobe.stock.com)

Evotec: € 7.5 m grant for development of COVID-19 therapeutic

Evotec SE announced that the Company has been selected by the German Federal Ministry of Education and Research (“BMBF”) to receive a grant for the ...

Read more …